Share this article
Share this article
CHICAGO, April 20, 2021 /PRNewswire/ Innovative tech company Kalderos today released its 2021 annual report. The report highlights the company s perspective on key challenges in the drug channel, leverages unique data to provide insights into drug discount programs, and advocates for a new model that utilizes platform technology to make drugs more affordable for patients. As we dive deeper into 2021, we see big developments on the horizon for the business of healthcare, said Kalderos CEO Jeremy Docken. Industry trends are driving change and so is the massive impact of COVID-19. A new administration is tackling drug pricing. During this pivotal moment, it s the perfect time to launch our inaugural annual report.
AstraZeneca Moves for Summary Judgment in HHS 340B Drug Pricing Program Suit
lawstreetmedia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lawstreetmedia.com Daily Mail and Mail on Sunday newspapers.
What s in store for New York nonprofits in the state budget
cityandstateny.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from cityandstateny.com Daily Mail and Mail on Sunday newspapers.
The ACCC 47
th Annual Meeting & Cancer Center
Business Summit (AMCCBS) took place
virtually, March 1-5. The Cancer Center Business Summit was
co-founded in 2007 by Foley & Lardner LLP and CCBD Group as an
opportunity for members of the community oncology c-suite,
providers, vendors, payors, and others involved in the business of
oncology to share best practices, learn about newest technologies,
trends, and legal and business updates in the industry, and to
strategize to position themselves for success. In 2017, the Summit
joined forces with the Association of Community Cancer Centers
(ACCC), and the AMCCBS now serves as the prominent thought
leadership forum and annual conference on matters of policy,